Laboratory Software delivers pathology information system.
Share:
Press Release Summary:
PowerPath v9.0 anatomic pathology information system provides CAP protocol worksheet support, GYN cytology reporting with HPV reflex testing, case search tool, and laboratory worklist functionality. Compatible optional modules include immunohistochemistry resulting, enhanced outreach reporting, advanced histology barcoding, and cancer registry interface. PowerPath is targeted for laboratories that offer surgical pathology, cytopathology, dermatopathology, and autopsy services.
Original Press Release:
IMPAC Introduces PowerPath® Version 9.0
Anatomic Pathology Information System with CAP Protocol Worksheets, Enhanced GYN Cytology Reporting
MOUNTAIN VIEW, Calif., Feb. 13 / -- IMPAC Medical Systems, Inc., part of the Elekta Group and a leading provider of information technology solutions for pathology and oncology, today introduces PowerPath version 9.0 anatomic pathology information system. New features in version 9.0 include CAP Protocol Worksheet support with SNOMED CT resulting -- which assists with ACS and CAP regulatory compliance, enhanced GYN Cytology Reporting with HPV reflex testing, an advanced case search tool, and laboratory worklist enhancements. PowerPath provides unmatched performance in managing laboratories that offer surgical pathology, cytopathology, dermatopathology, and autopsy services.
The new CAP Protocol Worksheets, designed to meet the requirements of the American College of Surgeons, allows the user to advance effortlessly through each CAP cancer worksheet, selecting data responses that are written to the patient report and stored discretely for easy retrieval. The CAP data elements are linked to SNOMED CT codes that can be transmitted through a results interface.
PowerPath version 9.0 also includes an enhanced GYN Cytology Reporting tool with configurable HPV Reflex Testing for pap smears. This allows facility-specific or referring-physician-specific rules for the type of pap results that require HPV follow-up tests.
In addition, IMPAC is introducing new optional modules and interfaces that are compatible with version 9.0, including Immunohistochemistry Resulting, Enhanced Outreach Reporting, advanced histology barcoding, and a cancer registry interface. These optional modules streamline resulting, increase report format options including color-coded body site maps for GI and prostate specimens, and facilitate specimen tracking to improve patient safety.
"This is a major release with many new features, enhancements and options," stated George Rugg, vice president for IMPAC's Laboratory Systems group. "We have worked very closely with customers and industry leaders to bring this new functionality to the lab, and we are confident our users will be pleased with the results."
Demonstrations of PowerPath version 9.0 will be available at IMPAC's booth at the annual meeting of the United States and Canadian Academy of Pathology (USCAP) in Atlanta, GA from February 13-15, 2006, Lab InfoTech Summit in Las Vegas, NV from March 1-3, 2006 and at CLMA/ThinkLab in Charlotte, NC from March 19-21, 2006. Further information can be found online at impac.com/pathology.
For more information, please contact:
Julie DeSantis, LIS Market Manager, IMPAC Medical Systems, Inc.
Tel: +1 408-362-2267, e-mail: jdesantis@impac.com
About IMPAC Medical Systems
IMPAC Medical Systems, Inc., a company in the Elekta Group, provides comprehensive healthcare IT solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC's open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory, and cancer registry. With products that range from diagnosis and treatment through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency, and quality patient care. For more information about IMPAC's products or services, please call 888-GO-IMPAC or visit www.impac.com.
About Elekta
Elekta is an international medical-technology group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective. With approx. 1700 employees, Elekta's corporate headquarters is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta's products or services, please visit www.elekta.com.
Source: IMPAC Medical Systems, Inc.
Web site: www.impac.com/
